Clinical Trials Browser

OTHER × Glioblastoma × Colony-Stimulating Factors × Clear all

NCT02455557 2026-03-30

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Phase 2 Active not recruiting

66 enrolled 11 charts

Glioblastoma, Gliosarcoma

NCT01250470 2017-02-27

Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma

Phase 1 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma